Fox 29: COVID-19 patients with blood cancers benefit from convalescent plasma, study shows
July 5, 2021
Dr. Dimpy Shah, Mays Cancer Center and Department of Population Health Sciences, is quoted in this story. Read more
MSN: 6% of cancer patients show little response to the COVID-19 vaccines
July 5, 2021
Dimpy P. Shah, MD, PhD, and Ruben Mesa, MD, of the Mays Cancer Center, were quoted in a story about a study that shows more than five percent of cancer patients exhibit no immune response to the two-shot COVID-19 vaccine. Read more
The Sacramento Bee: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Sacramento Bee addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
The Olympian: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of The Olympian addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
Miami Herald: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Miami Herald addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
Idaho Statesman: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Idaho Statesman addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story